Status:
COMPLETED
Evaluate and Optimize an Online Care Model for PrEP Delivery: Pilot Study
Lead Sponsor:
University of Washington
Collaborating Sponsors:
Bill and Melinda Gates Foundation
Fred Hutchinson Cancer Center
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Daily oral pre-exposure prophylaxis (PrEP) is highly effective at preventing HIV acquisition, but uptake in Kenya remains low. Barriers to clinic-based PrEP delivery exist (e.g., long wait times, stig...
Detailed Description
Online PrEP may help overcome patient- and provider-level barriers to facility-delivered PrEP. At the patient-level, online PrEP may increase privacy and convenience by enabling patients to receive Pr...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Accessed MYDAWA Services for HIVST or requested PrEP information through MYDAWA
- Are interested in and willing to take PrEP and are willing to pay for the PrEP delivery cost
- Be willing to pay for a blood-based HIVST and delivery cost
- Self-reported HIV negative
- Are able to access the MyDAWA platform using computer or a smartphone for the duration of the study
- Are able to access the internet
- Are able to read and comprehend English
- Are living in or willing to travel to the Nairobi area to receive virtual PrEP services
- Are able and willing to provide informed consent electronically.
Exclusion
Key Trial Info
Start Date :
October 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
2357 Patients enrolled
Trial Details
Trial ID
NCT05377138
Start Date
October 24 2022
End Date
December 31 2023
Last Update
May 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jomo Kenyatta University of Agriculture and Technology
Nairobi, Kenya